Capecitabine, Oxaliplatin, and Pembrolizumab

About

Membership operator: AND

Therapies: 3

Therapies

Capecitabine (tx:ncit:C1794)

Oxaliplatin (tx:ncit:C1181)

Pembrolizumab (tx:ncit:C106432)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) HER2-negative Adenocarcinoma of the Gastroesophageal Junction Capecitabine, Oxaliplatin, Pembrolizumab